Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: The treatment for patients with high-grade gliomas includes surgical resection of tumor, radiotherapy, and temozolomide chemotherapy. However, some patients do not respond to temozolomide due to a methylation reversal mechanism by the enzyme O-methylguanine-DNA-methyltransferase (MGMT). In patients receiving treatment with temozolomide, this biomarker has been used as a prognostic factor. However, not all patients respond in the same way, which suggests the existence of other proteins involved in resistance to temozolomide chemotherapy.

Methods: A group of thirty-one patients was recruited who were clinically and pathologically diagnosed with high-grade gliomas. The sequencing of 324 genes related to different types of cancer was performed to detect mutations. Subsequently, a statistical analysis was conducted to determine the mutated genes that were most related to resistance to treatment.

Results: According to the Stupp protocol and metronomic dose of the temozolomide treatment, the mutated genes related to the second relapse of patients with high-grade glioma were , , , and .

Conclusions: Considering the results obtained, we suggest that mutations in the four genes and methylation of the gene promoter that codes for the MGMT protein could be related to response to treatment with temozolomide.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11673431PMC
http://dx.doi.org/10.3390/biomedicines12122777DOI Listing

Publication Analysis

Top Keywords

patients high-grade
12
high-grade gliomas
12
mutations genes
8
resistance temozolomide
8
patients respond
8
treatment temozolomide
8
mutated genes
8
temozolomide
7
patients
7
genes relationship
4

Similar Publications

Introduction: The optimal surveillance for mucinous appendix cancer (MAC) after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) remains unclear. We identified postoperative periods reflecting significant changes in recurrence probability.

Methods: A prospective database (1998-2024) of patients with stage IV MAC with low-grade (LGMCP), high-grade (HGMCP), and signet-ring cell (SRC) histology treated with initial complete (CC-0/1) CRS/HIPEC was analyzed.

View Article and Find Full Text PDF

Introduction: Time to initiation of therapy in oncological care is an influential factor in disease progression and survival outcomes in many cancer types. We aim to identify factors associated with delayed time to treatment (TTT) in high-grade osteosarcoma and its relationship to disease-specific survival (DSS).

Methods: The SEER database was queried for biopsy-confirmed cases of high-grade osteosarcoma between 2000 and 2021 using ICD-O-3 histology codes 9180/3-9194/3 and primary site codes C40.

View Article and Find Full Text PDF

Background: Anal squamous cell cancer incidence has risen 2.2% each year over the past decade. Current screening includes anal cytology and high-resolution anoscopy but is burdened with sampling error and patient discomfort.

View Article and Find Full Text PDF

Purpose: The purpose of this prospective study was to investigate the effect of Kaplan fibres (KF), anterolateral ligament (ALL) and lateral meniscus (LM) injuries on preoperative anterolateral rotational instability (ALRI) in anterior cruciate ligament (ACL)-injured knees. It was hypothesised that injuries to the ALC (i.e.

View Article and Find Full Text PDF

Acute Generalized Exanthematous Pustulosis: A Case Report.

Cureus

August 2025

Internal Medicine, Centro Médico Nacional Siglo XXI, Mexico City, MEX.

Acute generalized exanthematous pustulosis (AGEP) is a rare, potentially severe cutaneous adverse reaction characterized by the rapid onset of numerous small, sterile pustules on edematous erythema, commonly accompanied by systemic symptoms such as high-grade fever and neutrophilic leukocytosis. AGEP is most frequently triggered by medications, especially antibiotics, though infections and other exposures can also be causative. We report the case of a previously healthy 27-year-old male patient who developed a febrile pustular eruption with systemic involvement.

View Article and Find Full Text PDF